Otology Japan
Online ISSN : 1884-1457
Print ISSN : 0917-2025
ISSN-L : 0917-2025
Volume 33, Issue 2
Displaying 1-8 of 8 articles from this issue
  • Yasue Uchida, Saiko Sugiura
    2023 Volume 33 Issue 2 Pages 79-84
    Published: 2023
    Released on J-STAGE: November 28, 2023
    JOURNAL FREE ACCESS

    Evidence on whether hearing compensation with hearing aids and cochlear implants are beneficial on cognitive decline/dementia and brain morphology is limited, although hearing loss is recognized as a risk for dementia. In 2023, the systematic review and meta-analysis on the effects of hearing compensation on cognitive decline/dementia was published. The meta-analysis results indicated that hearing aid users had a 19% lower risk of long-term cognitive decline compared with that of nonusers, and using hearing restorative devices (hearing aids and cochlear implants) was associated with significantly 3% improvement in short-term general cognitive test scores. Including the results of our study selected within this review, we outline the meaning of auditory compensation focusing on changes in cognitive function and brain morphology. Since a cure for dementia remains unavailable, societal expectations for hearing loss approaches have increased, and the effects of auditory compensation on cognitive function should be continually verified.

    Download PDF (723K)
  • Shintaro Baba
    2023 Volume 33 Issue 2 Pages 85-89
    Published: 2023
    Released on J-STAGE: November 28, 2023
    JOURNAL FREE ACCESS

    Presently, the study evaluated the efficacy of high-dose corticosteroid therapy in children with severe acute facial paralysis (FP). The study enrolled 10 pediatric patients with complete FP who received prednisolone (PSL) 3–4 mg/kg/day for two to three days followed by a 10-day taper (child high-dose group). Eight pediatric patients who received PSL 0.5–1 mg/kg/d were enrolled in the child low-dose group, and nine adult patients (25–64 years) who received high-dose PSL 200 mg for two to three days followed by a 10-day taper were enrolled in the adult high-dose group. Children receiving PSL 3–4 mg/kg/day achieved better recovery and less synkinesis than that of those treated with low-dose PSL (0.5–1 mg/kg/day).

    The efficacy of mirror biofeedback rehabilitation for synkinesis in children with severe acute FP was evaluated. The patients initiated daily facial biofeedback rehabilitation using a mirror upon the first sign of muscle contraction on the affected side and were instructed to maintain their eyes symmetrically open using a mirror during mouth movements. The training continued for 12 months after the onset of FP. The degree of oral-ocular synkinesis was evaluated by the degree of asymmetry in eye opening width during mouth movements. Children who underwent mirror biofeedback rehabilitation had less synkinesis than that of the infant-and-toddler control group, suggesting that mirror biofeedback rehabilitation is more effective in preventing synkinesis exacerbation in children.

    Download PDF (730K)
feedback
Top